Cannabis Stock Gainers And Losers From May 31, 2024 - Quantisnow
| THCT Stock | USD 0.0005 0.00 0.00% |
Slightly above 55% of THC Therapeutics' private investors are presently thinking to get in. The analysis of overall sentiment of trading THC Therapeutics pink sheet suggests that some investors are interested at this time. THC Therapeutics' investing sentiment can be driven by a variety of factors including economic data, THC Therapeutics' earnings reports, geopolitical events, and overall market trends.
THC |
Cannabis Stock Gainers And Losers From May 31, 2024 Quantisnow
Read at news.google.com
 |
THC Therapeutics Fundamental Analysis
We analyze THC Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of THC Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of THC Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Z Score
Z Score Comparative Analysis
THC Therapeutics is currently under evaluation in z score category among its peers. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
THC Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with THC Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of THC Therapeutics could also be used in its relative valuation, which is a method of valuing THC Therapeutics by comparing valuation metrics with similar companies.
Peers
THC Therapeutics Related Equities
| ESALF | Eisai Co | 0.10 | ||||
| MKGAF | MERCK Kommanditgesells | 3.82 | ||||
| CXXIF | C21 Investments | 4.17 |
Additional Tools for THC Pink Sheet Analysis
When running THC Therapeutics' price analysis, check to measure THC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Therapeutics is operating at the current time. Most of THC Therapeutics' value examination focuses on studying past and present price action to predict the probability of THC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Therapeutics' price. Additionally, you may evaluate how the addition of THC Therapeutics to your portfolios can decrease your overall portfolio volatility.